Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients.

Por Zuraw, B L, Curd, J G
Publicado em 1986

Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis.

Por Guerne, P A, Zuraw, B L, Vaughan, J H, Carson, D A, Lotz, M
Publicado em 1989

Bradykinin stimulates NF-kappaB activation and interleukin 1beta gene expression in cultured human fibroblasts.

Por Pan, Z K, Zuraw, B L, Lung, C C, Prossnitz, E R, Browning, D D, Ye, R D
Publicado em 1996

Immunoglobulin E-rheumatoid factor in the serum of patients with rheumatoid arthritis, asthma, and other diseases.

Por Zuraw, B L, O'Hair, C H, Vaughan, J H, Mathison, D A, Curd, J G, Katz, D H
Publicado em 1981

Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate

Por Zuraw, B. L., Cicardi, M., Longhurst, H. J., Bernstein, J. A., Li, H. H., Magerl, M., Martinez‐Saguer, I., Rehman, S. M. M., Staubach, P., Feuersenger, H., Parasrampuria, R., Sidhu, J., Edelman, J., Craig, T.
Publicado no Allergy (2015)